ID   5EAS_TOBAC              Reviewed;         548 AA.
AC   Q40577;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   29-APR-2008, sequence version 3.
DT   22-JUL-2015, entry version 107.
DE   RecName: Full=5-epi-aristolochene synthase;
DE            Short=EAS;
DE            EC=4.2.3.61;
GN   Name=EAS3;
GN   and
GN   Name=EAS4;
OS   Nicotiana tabacum (Common tobacco).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; asterids; lamiids; Solanales; Solanaceae;
OC   Nicotianoideae; Nicotianeae; Nicotiana.
OX   NCBI_TaxID=4097;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], PROTEIN SEQUENCE OF 56-73,
RP   AND INDUCTION.
RC   STRAIN=cv. NK 326;
RX   PubMed=1438319; DOI=10.1073/pnas.89.22.11088;
RA   Facchini P.J., Chappell J.;
RT   "Gene family for an elicitor-induced sesquiterpene cyclase in
RT   tobacco.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:11088-11092(1992).
RN   [2]
RP   SEQUENCE REVISION TO 35.
RA   O'Maille P.E.;
RL   Unpublished observations (APR-2008).
RN   [3]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF
RP   TYR-520.
RX   DOI=10.1021/ja993584h;
RA   Rising K.A., Starks C.M., Noel J.P., Chappell J.;
RT   "Demonstration of germacrene A as an intermediate in 5-epi-
RT   aristolochene synthase catalysis.";
RL   J. Am. Chem. Soc. 122:1861-1866(2000).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) IN COMPLEX WITH MAGNESIUM IONS
RP   AND SUBSTRATE, AND SEQUENCE REVISION.
RX   PubMed=9295271; DOI=10.1126/science.277.5333.1815;
RA   Starks C.M., Back K., Chappell J., Noel J.P.;
RT   "Structural basis for cyclic terpene biosynthesis by tobacco 5-epi-
RT   aristolochene synthase.";
RL   Science 277:1815-1820(1997).
CC   -!- FUNCTION: Catalyzes the cyclization of trans,trans-farnesyl
CC       diphosphate (FPP) to the bicyclic intermediate 5-epi-
CC       aristolochene, initial step in the conversion of FPP to the
CC       sesquiterpenoid antifungal phytoalexin capsidiol. Produces
CC       germacrene A as an enzyme-bound intermediate that is not released
CC       by the enzyme, but is further cyclized to produce the bicyclic 5-
CC       epi-aristolochene.
CC   -!- CATALYTIC ACTIVITY: (2E,6E)-farnesyl diphosphate = (+)-5-
CC       epiaristolochene + diphosphate. {ECO:0000269|Ref.3}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:9295271};
CC       Note=Binds 3 Mg(2+) ions per subunit.
CC       {ECO:0000269|PubMed:9295271};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.3 uM for 2-trans,6-trans-farnesyl diphosphate
CC         {ECO:0000269|Ref.3};
CC   -!- PATHWAY: Secondary metabolite biosynthesis; terpenoid
CC       biosynthesis.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:9295271}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- INDUCTION: By fungal elicitor. {ECO:0000269|PubMed:1438319}.
CC   -!- DOMAIN: The Asp-Asp-Xaa-Xaa-Asp/Glu (DDXXD/E) motif is important
CC       for the catalytic activity, presumably through binding to Mg(2+).
CC   -!- MISCELLANEOUS: PubMed:1438319 indicates the presence of at least
CC       two genes coding for the same protein.
CC   -!- SIMILARITY: Belongs to the terpene synthase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L04680; AAA19216.1; -; Unassigned_RNA.
DR   PIR; T03714; T03714.
DR   PDB; 1HX9; X-ray; 3.50 A; A=1-548.
DR   PDB; 1HXA; X-ray; 2.32 A; A=1-548.
DR   PDB; 1HXC; X-ray; 2.25 A; A=1-548.
DR   PDB; 1HXG; X-ray; 2.90 A; A=1-548.
DR   PDB; 3LZ9; X-ray; 2.28 A; A=1-548.
DR   PDB; 3M00; X-ray; 2.10 A; A=1-548.
DR   PDB; 3M01; X-ray; 2.60 A; A=1-548.
DR   PDB; 3M02; X-ray; 2.50 A; A=1-548.
DR   PDB; 4DI5; X-ray; 2.30 A; A=14-548.
DR   PDB; 4RNQ; X-ray; 2.47 A; A=1-548.
DR   PDB; 5EAS; X-ray; 2.25 A; A=1-548.
DR   PDB; 5EAT; X-ray; 2.80 A; A=1-548.
DR   PDB; 5EAU; X-ray; 2.15 A; A=1-548.
DR   PDBsum; 1HX9; -.
DR   PDBsum; 1HXA; -.
DR   PDBsum; 1HXC; -.
DR   PDBsum; 1HXG; -.
DR   PDBsum; 3LZ9; -.
DR   PDBsum; 3M00; -.
DR   PDBsum; 3M01; -.
DR   PDBsum; 3M02; -.
DR   PDBsum; 4DI5; -.
DR   PDBsum; 4RNQ; -.
DR   PDBsum; 5EAS; -.
DR   PDBsum; 5EAT; -.
DR   PDBsum; 5EAU; -.
DR   ProteinModelPortal; Q40577; -.
DR   SMR; Q40577; 21-548.
DR   BioCyc; MetaCyc:EAS-MONOMER; -.
DR   BRENDA; 4.2.3.61; 3645.
DR   UniPathway; UPA00213; -.
DR   EvolutionaryTrace; Q40577; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0010333; F:terpene synthase activity; IEA:InterPro.
DR   GO; GO:0016114; P:terpenoid biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 1.10.600.10; -; 1.
DR   Gene3D; 1.50.30.10; -; 1.
DR   InterPro; IPR008949; Isoprenoid_synthase_dom.
DR   InterPro; IPR001906; Terpene_synth_N.
DR   InterPro; IPR005630; Terpene_synthase_metal-bd.
DR   InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR   Pfam; PF01397; Terpene_synth; 1.
DR   Pfam; PF03936; Terpene_synth_C; 1.
DR   SUPFAM; SSF48239; SSF48239; 1.
DR   SUPFAM; SSF48576; SSF48576; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; Lyase; Magnesium;
KW   Metal-binding.
FT   CHAIN         1    548       5-epi-aristolochene synthase.
FT                                /FTId=PRO_0000186438.
FT   MOTIF       301    305       DDXXD motif.
FT   METAL       301    301       Magnesium 1.
FT                                {ECO:0000269|PubMed:9295271}.
FT   METAL       301    301       Magnesium 2.
FT                                {ECO:0000269|PubMed:9295271}.
FT   METAL       305    305       Magnesium 1.
FT                                {ECO:0000269|PubMed:9295271}.
FT   METAL       305    305       Magnesium 2.
FT                                {ECO:0000269|PubMed:9295271}.
FT   METAL       444    444       Magnesium 3.
FT                                {ECO:0000269|PubMed:9295271}.
FT   METAL       448    448       Magnesium 3.
FT                                {ECO:0000269|PubMed:9295271}.
FT   METAL       452    452       Magnesium 3.
FT                                {ECO:0000269|PubMed:9295271}.
FT   MUTAGEN     520    520       Y->F: Loss of production of
FT                                aristolochene, and accumulation of the
FT                                intermediate germacrene A.
FT                                {ECO:0000269|Ref.3}.
FT   CONFLICT     35     35       K -> D (in Ref. 1; AAA19216).
FT                                {ECO:0000305}.
FT   CONFLICT     42     42       Y -> YIY (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     44     44       K -> Q (in Ref. 1; AAA19216).
FT                                {ECO:0000305}.
FT   CONFLICT     55     55       N -> S (in Ref. 1; AAA19216).
FT                                {ECO:0000305}.
FT   CONFLICT     62     62       M -> R (in Ref. 1; AAA19216).
FT                                {ECO:0000305}.
FT   CONFLICT     73     73       T -> I (in Ref. 1; AAA19216).
FT                                {ECO:0000305}.
FT   CONFLICT     89     89       D -> E (in Ref. 1; AAA19216).
FT                                {ECO:0000305}.
FT   CONFLICT    388    388       T -> M (in Ref. 1; AAA19216).
FT                                {ECO:0000305}.
FT   TURN         24     29       {ECO:0000244|PDB:3M00}.
FT   HELIX        36     57       {ECO:0000244|PDB:3M00}.
FT   HELIX        64     76       {ECO:0000244|PDB:3M00}.
FT   HELIX        80     82       {ECO:0000244|PDB:3M00}.
FT   HELIX        84     97       {ECO:0000244|PDB:3M00}.
FT   HELIX       104    116       {ECO:0000244|PDB:3M00}.
FT   HELIX       123    129       {ECO:0000244|PDB:3M00}.
FT   STRAND      134    136       {ECO:0000244|PDB:5EAU}.
FT   HELIX       138    142       {ECO:0000244|PDB:3M00}.
FT   HELIX       144    154       {ECO:0000244|PDB:3M00}.
FT   HELIX       162    164       {ECO:0000244|PDB:3M00}.
FT   HELIX       167    178       {ECO:0000244|PDB:3M00}.
FT   HELIX       179    181       {ECO:0000244|PDB:3M00}.
FT   HELIX       186    195       {ECO:0000244|PDB:3M00}.
FT   HELIX       203    213       {ECO:0000244|PDB:3M00}.
FT   HELIX       215    217       {ECO:0000244|PDB:3M00}.
FT   HELIX       223    252       {ECO:0000244|PDB:3M00}.
FT   TURN        253    255       {ECO:0000244|PDB:4RNQ}.
FT   HELIX       256    259       {ECO:0000244|PDB:3M00}.
FT   HELIX       267    277       {ECO:0000244|PDB:3M00}.
FT   HELIX       281    283       {ECO:0000244|PDB:3M00}.
FT   HELIX       284    305       {ECO:0000244|PDB:3M00}.
FT   HELIX       310    322       {ECO:0000244|PDB:3M00}.
FT   HELIX       325    330       {ECO:0000244|PDB:3M00}.
FT   HELIX       333    354       {ECO:0000244|PDB:3M00}.
FT   TURN        355    357       {ECO:0000244|PDB:3M00}.
FT   HELIX       359    361       {ECO:0000244|PDB:3M00}.
FT   HELIX       362    385       {ECO:0000244|PDB:3M00}.
FT   HELIX       391    398       {ECO:0000244|PDB:3M00}.
FT   HELIX       400    402       {ECO:0000244|PDB:3M00}.
FT   HELIX       404    413       {ECO:0000244|PDB:3M00}.
FT   HELIX       420    427       {ECO:0000244|PDB:3M00}.
FT   HELIX       431    447       {ECO:0000244|PDB:3M00}.
FT   HELIX       449    454       {ECO:0000244|PDB:3M00}.
FT   HELIX       461    469       {ECO:0000244|PDB:3M00}.
FT   HELIX       473    494       {ECO:0000244|PDB:3M00}.
FT   STRAND      496    498       {ECO:0000244|PDB:3M00}.
FT   HELIX       503    505       {ECO:0000244|PDB:3M00}.
FT   HELIX       507    519       {ECO:0000244|PDB:3M00}.
FT   TURN        520    522       {ECO:0000244|PDB:3LZ9}.
FT   TURN        523    525       {ECO:0000244|PDB:3M02}.
FT   TURN        526    528       {ECO:0000244|PDB:4DI5}.
FT   HELIX       531    542       {ECO:0000244|PDB:3M00}.
SQ   SEQUENCE   548 AA;  62987 MW;  9FE25FF361A68BF1 CRC64;
     MASAAVANYE EEIVRPVADF SPSLWGDQFL SFSIKNQVAE KYAKEIEALK EQTRNMLLAT
     GMKLADTLNL IDTIERLGIS YHFEKEIDDI LDQIYNQNSN CNDLCTSALQ FRLLRQHGFN
     ISPEIFSKFQ DENGKFKESL ASDVLGLLNL YEASHVRTHA DDILEDALAF STIHLESAAP
     HLKSPLREQV THALEQCLHK GVPRVETRFF ISSIYDKEQS KNNVLLRFAK LDFNLLQMLH
     KQELAQVSRW WKDLDFVTTL PYARDRVVEC YFWALGVYFE PQYSQARVML VKTISMISIV
     DDTFDAYGTV KELEAYTDAI QRWDINEIDR LPDYMKISYK AILDLYKDYE KELSSAGRSH
     IVCHAIERMK EVVRNYNVES TWFIEGYTPP VSEYLSNALA TTTYYYLATT SYLGMKSATE
     QDFEWLSKNP KILEASVIIC RVIDDTATYE VEKSRGQIAT GIECCMRDYG ISTKEAMAKF
     QNMAETAWKD INEGLLRPTP VSTEFLTPIL NLARIVEVTY IHNLDGYTHP EKVLKPHIIN
     LLVDSIKI
//
